TC BioPharm (Holdings) plc Quarterly Liabilities in GBP from Q4 2022 to Q1 2024

Taxonomy & unit
us-gaap: GBP
Description
Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.
Summary
TC BioPharm (Holdings) plc quarterly Liabilities history and growth rate from Q4 2022 to Q1 2024.
  • TC BioPharm (Holdings) plc Liabilities for the quarter ending March 31, 2024 was £6.18M.
Liabilities, Quarterly (GBP)
Liabilities, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 6.18M Mar 31, 2024 10-Q 2024-05-15
Q4 2023 6.25M -4.71M -43% Dec 31, 2023 10-Q 2024-05-15
Q4 2022 11M -13.6M -55.4% Dec 31, 2022 10-K 2024-04-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.